Effects of High Dose Methotrexate and Delayed Elimination on Myelotoxicity Progression in Children with Acute Lymphoblastic Leukemia
Background and study aim: Methotrexate (MTX) as an antineoplastic agent inhibits dihydrofolate reductase. The frequency of high dose methotrexate (HDMTX) associated toxicity is variable. In this study we investigate the frequency of myelosuppression following 5 and 9 days of HDMTX infusion and MTX d...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Zagazig University, Faculty of Medicine, Endemic and Tropical Medicine Department
2017-03-01
|
| Col·lecció: | Afro-Egyptian Journal of Infectious and Endemic Diseases |
| Matèries: | |
| Accés en línia: | https://aeji.journals.ekb.eg/article_8993_83abd9b8c54cc998d929f2199ba7069f.pdf |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|